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ABSTRACT 
Background: Benign prostatic hyperplasia (BPH) is one of the most common benign tumors on elderly 
man. BPH manifests as lower urinary tract symptoms (LUTS). To determine subjectively the symptom 
severity of LUTS, quantitatively, it was used a diagnostic tool called IPSS. However, IPSS individually 
is not enough in enforcement of definitive diagnosis man with LUTS. There were some other 
diagnostics tools used in diagnosing BPH, the other one is uroflowmetry examination that is objective. 
This research aims are to know the correlation between IPSS and Qmax on uroflowmetry in BPH 
patients at Abdul Wahab Sjahranie Hospital in Samarinda. 
Methods: This research is an analytic survey with observational design, cross sectional. The subject of 
this research is BPH patients with LUTS at Abdul Wahab Sjahranie Hospital in Samarinda on March 
until May 2019. Data is collected primarily through the IPSS’s questionnaire filled by the patient. Data 
flow rate obtained through uroflowmetry examination with emphasis on maximum flow rate (Qmax). 
Results: This research found that BPH is majorly found on group age 60-69 years (45%). IPSS with 
moderate symptom severity mostly found on patient (60%). Nocturia (90.5%) and incomplete emptying 
(85%) is the most frequent symptoms found. The analysis results showed that IPSS had a moderate 
negative correlation with Qmax on uroflowmetry (r = -0,567; p = 0,009). 
Conclusions: There was correlation between IPSS and Qmax on uroflowmetry of BPH patients at 
Abdul Wahab Sjahranie Hospital in Samarinda. 
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INTRODUCTION 
Benign prostatic hyperplasia (BPH) is the proliferation of smooth muscle and epithelial cells in 
the transitional zone of the prostate1. McNeal (1976) divides the prostate into five zones namely 
peripheral zones, central zones, transitional zones, anterior fibromuscular zones, and periurethral zones. 
Most BPH originates from the prostate transitional zone.2 
BPH is one of the most common benign tumors in elderly men3. BPH is experienced by 8% men 
who are  40 years and then increased by 50% at age  60 years and 80% at age  90 years.4 Overview 
of hospital prevalence at Cipto Mangunkusumo Hospital (RSCM) found 3804 cases and the average 
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age of sufferers of 66.61 years in 1994-2013 but the exact incidence rate of BPH in Indonesia has never 
been examined.5 The description of BPH cases in Abdul Wahab Sjahranie Hospital in Samarinda 
according to the research by Gautama (2010) said that there were 1020 medical records with a diagnosis 
of BPH in the period 1 August 2008 - 31 July 2010. 
Patients with BPH suffer prostate enlargement occurs which results in bladder outlet obstruction 
(BOO) and causes various symptoms of the lower urinary tract (LUTS) .7 However, the presence of 
BPH does not always cause LUTS symptoms. In contrast, LUTS symptoms do not always arise due to 
the presence of BPH.8 
Obstruction symptoms due to prostate enlargement and the degree of symptoms on BPH patients 
can be assessed using a scoring system namely the International Prostate Symptom Score (IPSS) 
developed by the American Urological Association (AUA) and standardized by the World Health 
Organization (WHO) .5 IPSS is a diagnostic tool that is it is subjective but determines the degree of 
LUTS symptoms quantitatively.3 Its use is routinely recommended for men with LUTS when 
diagnosing and evaluating their treatment.9 However, IPSS alone is not sufficient in definitive diagnosis 
of men with LUTS.9,10 
There are several diagnostic tools used in diagnosing BPH, including urinalysis, PSA 
examination, uroflowmetry, PVR and image analysis.3 Uroflowmetry is a diagnostic tool for objective 
urine examination.7 One of the information obtained from this examination is the maximum urine 
emission rate (Qmax) which is related to the presence of BOO.1 Uroflowmetry can be used to link 
symptoms with objective findings 9. 
So on the basis of this knowledge the author wants to examine the correlation between the 
international prostatic symptom score (IPSS) with Qmax in the uroflowmetry of benign prostatic 
hyperplasia (BPH) patients in Abdul Wahab Sjahranie Regional Hospital Samarinda.  
MATERIAL AND METHOD 
 This study uses analytic survey methods to analyze the dynamics of correlation between 
phenomena with cross sectional observational designs. The research was conducted at the Polyclinic of 
Abdul Wahab Sjahranie Hospital in Samarinda from March to May 2019. 
 The population in this study were all patients diagnosed with BPH by urology specialist in the 
Urology Polyclinic Abdul Wahab Sjahranie Hospital in Samarinda in March-May 2019. Samples in this 
study were all patients diagnosed with BPH by urology specialists in the Urology Polyclinic at Abdul 
Wahab Sjahranie Regional Hospital in Samarinda and fulfilled March-May 2019. criteria that have been 
determined in March-May 2019. Sampling in this study using purposive sampling techniques with the 
following criteria. 
Inclusion Criteria 
1) BPH patients with symptoms of LUTS without complications that have been diagnosed by a 
urologist. 
2) Patients who do uroflowmetry examination with urine volume > 150 ml. 
3) Patients who re-do uroflowmetry with urine volume > 150 ml. 
4) Patients who are willing to participate in the study. 
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Exclusion Criteria 
1) Patients with LUTS but not diagnosed with BPH. 
2) Patients who have received BPH therapy. 
  The independent variable in this study is the IPSS score collected primarily through the IPSS 
questionnaire filled out by the patient. The dependent variable is the maximum urine emission rate 
(Qmax) obtained through uroflowmetry examination. Correlations between variables were analyzed 
using the Pearson test. 
RESULT AND DISCUSSION 
 This research was conducted from March to May 2019 at the Urology Polyclinic of Abdul 
Wahab Sjahranie Hospital in Samarinda with a total sample of 20 people. In this study, the 
average age of BPH patients was 60.45 years with a minimum age of 48 years and a maximum 
age of 71 years. The highest number of BPH patients is in the age group of 60-69 years as many 
as 9 people (45%) (Table 1). The total IPSS score of 5 is the smallest value and the total score 
of IPSS 31 is the largest value. IPSS with moderate symptoms (score 8-19) was the most 
common, occurring in 12 patients (60%) (Table 2). In this study it was also found that the most 
common symptom found in BPH patients with LUTS was nocturia (90.5%) and they felt there 
was residual after micturition or incomplete emptying (85%) (Figure 1). This study obtained 
an average Qmax of 10.38 ml / s with a minimum Qmax of 7 ml / s and a maximum Qmax of 
15.6 ml / s. BPH patients who experienced obstruction based on Qmax values <10 ml / s were 
found in 7 people (35%) (Table 3). 
 The correlation of IPSS and Qmax on uroflowmetry is known through Pearson test 
according to the results of normality and homogeneity test (Table 4). Based on the Pearson test 
results obtained p value < 0.05 which indicates that the correlation of IPSS with Qmax on 
uroflowmetry of BPH patients is significant. Correlation coefficient (r) -0.567 indicates 
moderate correlation strength and negative correlation (Table 5). 
 


























Total 20 100 
IPSS Score Quantity (people) Percentage (%) 
Mild Symptoms (0-7) 1 5 
Moderate Symptoms (8-19) 12 60 
Severe Symptoms (20-35) 7 35 
Total 20 100 
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Table 3. The Distribution of Maximum Urine Beam Velocity in BPH Patients at Abdul Wahab Sjahranie 










Table 5. Analysis of IPSS correlation with Qmax on uroflowmetry of BPH patients at Abdul Wahab Sjahranie 
Hospital in Samarinda 







Total 20 100 
 
Figure 1. The Distribution of Symptoms that Appear in BPH Patients at Abdul Wahab Sjahranie Hospital in 
Samarinda 
 
 BPH is the most common benign tumor in men and its incidence is related to age3. 
Research on 20 BPH patients at Abdul Wahab Sjahranie Hospital in Samarinda found that the 
average age of patients was 60.45 years with a range of 48-71 years and most were in the 60-
69 years age group. This is in line with previous research which showed that the age of most 
BPH sufferers was found in the age group of 60-69 years with an average age of 64.385 years. 
The results of other studies showed the same result: the age group 60-69 years is the age group 
of the most BPH patients with an average age of 67.7 years and 65.2 years, respectively. This 
study shows an increase in the number of BPH patients with increasing age in accordance with 
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the previous statement that BPH is experienced by 8% in men who were in the category of age 
 40 years and then increased 50% at age 60 years and 80% at age 90 years. However, the 
decrease in the number of patients in the 70-79 age group is likely due to the age group having 
a smaller population than other age groups and many patients in that age group have 
experienced urinary retention when they visited the hospital so they cannot be sampled in this 
study. 
LUTS is a group of symptoms that are non-specific, non-organ specific, and related to 
age.14 Clinically, BPH manifests as LUTS.15 In this study, LUTS symptoms that appear in BPH 
patients are assessed through IPSS scoring. IPSS scoring is used as a guide to direct and 
determine the presence of obstruction and irritative symptoms that occur during the history of 
BPH patients. The results showed that IPSS with moderate symptoms was most found in 
patients (60%). Similar results were also obtained in other studies, 58.8% and 50.2% of BPH 
patients in the study had LUTS symptoms with moderate symptoms, respectively. Based on 
the results of these studies, it can be assumed that most BPH patients came to the hospital when 
the perceived symptoms has increased to a moderate symptoms. 
In addition, this study showed that the most frequent symptoms of LUTS in BPH patients 
at Abdul Wahab Sjahranie Hospital in Samarinda were nocturia (90.5%) and they felt there 
was residual after micturition or incomplete emptying (85%). This is in line with studies that 
also found nocturia (71%) and incomplete emptying (59.9%) as the most common symptoms 
of LUTS in BPH patients. Symptoms of nocturia arise in BPH patients due to changes in the 
structure of the bladder due to overactivity of the detrusor muscle as compensation for 
obstruction due to prostate enlargement.15 Nocturia as the most frequent symptom in BPH 
patients may be due to several reasons namely the kidneys, bladder, and urethra sphincter that 
is innervated. by the parasympathetic nerve so that its stimulation will result in vasodilation, 
renal arteries, contraction of the bladder, and relaxation of the urethral sphincter where at night 
(especially during sleep) there is a decrease in the effect of sympathetic inhibition of the 
parasympathetic organs and increased parasympathetic stimulation that causes excitation of the 
organ which he supplies so that at night urine production will increase, bladder contractions 
increase, and weakening of the urethral sphincter tone. In addition, decreased antidiuretic 
hormone (ADH) associated with age and decreased control of the pituitary during sleep and 
the presence of post-void residuals due to incomplete micturition are also factors that may also 
increase the frequency of urination at night and cause nocturia to become the most common 
symptoms . 
In this study, there were more Qmax images of uroflowmetry of obese BPH patients 
(65%) compared to Qmax obstruction (35%) so that it was found that most BPH patients in 
Abdul Wahab Sjahranie Hospital in Samarinda did not experience symptoms of lower urinary 
obstruction assessed objective of uroflowmetry examination. 
Statistical analysis using the Pearson test showed p = 0.009 and r = -0.567 which showed 
that the correlation of IPSS with Qmax in uroflowmetry of BPH patients in Abdul Wahab 
Sjahranie Hospital was significant with moderate correlation strength and negative correlation. 
The results of this study are in line with research conducted by Bhomi et al. (2017) on 66 BPH 
JURNAL ILMU KESEHATAN VOL. 7 NO. 2 DECEMBER 2019 
E-ISSN : 2614-6703 
Received : 2019-07-08  Revised : 2019-12-06 Acceptance : 2019-12-12            Publish : 2019-12-31 
90 
patients which got the result that IPSS and Qmax had a strong correlation in the presence of a 
negative correlation (p <0.01, r = -0.701). The results of previous studies explained that 50 
BPH patients also showed that IPSS with Qmax in uroflowmetry had a significant correlation 
with strong correlation strength and negative correlation (p <0.001, r = -0.67). The results of 
other studies that show the same thing are studies of 50 BPH patients and studies of 366 BPH 
patients who also examine all parameters of uroflowmetry with the result that only Qmax is 
the most important parameter in uroflowmetry clinically. Both of these studies found that IPSS 
with Qmax on uroflowmetry had a significant correlation with weak correlation strengths and 
the presence of negative correlations, respectively with p = 0.0075, r = -0.368 and p = 0.0001, 
r = -0.318. The results of this study indicate that IPSS and Qmax in uroflowmetry are diagnostic 
tools that have proven to be meaningful in assessing BPH patients' symptoms at Abdul Wahab 
Sjahranie Hospital in Samarinda. 
CONCLUSION 
 Based on the results of the study, it can be concluded that there is a significant 
correlation with moderate correlation and a negative correlation between IPSS and Qmax on 
uroflowmetry of BPH patient at Abdul Wahab Hospital Sjahranie in Samarinda. 
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